PharmiWeb.com - Global Pharma News & Resources
13-Dec-2018

Nationwide Program Brings Hope Home to Lung Cancer Patients During the Holidays

SAN CARLOS, Calif. and RIDGEFIELD, Conn., Dec. 12, 2018 /PRNewswire/ -- For the second consecutive year, the Bonnie J. Addario Lung Cancer Foundation (ALCF) and Boehringer Ingelheim Pharmaceuticals, Inc., have come together to brighten lung cancer patients' holiday season through the "Bring Hope Home for the Holidays" partnership. This program is helping lung cancer patients make holiday memories across the nation through December 20, 2018.

With the support of ALCF, Boehringer Ingelheim volunteers are visiting lung cancer patients' homes and bringing good deeds to families. To help raise their spirits during the holidays, the volunteers will help lung cancer patients with holiday activities, such as trimming the tree, wrapping gifts, writing cards or hanging lights outside of the house.

"While the holidays are a wonderful and magical time for families, I personally recognize the hardships face by lung cancer patients this time of year," said Bonnie J. Addario, lung cancer survivor and founder and chair of the ALCF. "I was diagnosed with lung cancer during the holidays, and because of this, we have committed to making the season a little brighter for lung cancer patients and their families. The work that Boehringer Ingelheim and their amazing employees do through this program has a profound impact for these patients and their families."

"Bring Hope Home for the Holidays is a unique effort to give back to the lung cancer community and deliver cheer and joy to their homes during this special time of year," said Kelli Moran, senior vice president, specialty care, Boehringer Ingelheim Pharmaceuticals, Inc. "With the support of caring volunteers from Boehringer Ingelheim, we hope to make a positive difference in their lives and demonstrate the personal connection we feel with these remarkable people."

Despite being the most deadly form of cancer, the stigma of lung cancer leads to underfunding. In fact, according to The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, lung cancer is the number one cancer killer of men and women in every ethnic group in the U.S., taking more lives than breast, prostate and colon cancers combined. However, lung cancer research receives less funding than any other cancer, so it's important to understand that eight in 10 lung cancer patients never smoked or quit smoking decades ago.

To learn more about "Bring Hope Home for the Holidays," visit http://www.lungcancerfoundation.org/bringhopehome/

About "Bring Hope Home for the Holidays"
The Bonnie J. Addario Lung Cancer Foundation (ALCF) and Boehringer Ingelheim are committed to making this holiday season brighter, with their "Bring Hope Home for the Holidays" national effort. The program recognizes the hardships faced by lung cancer patients and, through the support of volunteers, will deliver holiday help and cheer to patients in their homes in 21 U.S. cities. For more information, visit http://www.lungcancerfoundation.org/bringhopehome/

About the Bonnie J. Addario Lung Cancer Foundation (ALCF)
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest international philanthropies (patient-founded, patient-focused and patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $30 million for lung cancer research and related programs. For more information about the ALCF please visit www.lungcancerfoundation.org or follow us on Facebook or Twitter.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, Conn., is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 50,000 employees. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families.  Our employees create and engage in programs that strengthen our communities. Please visit www.boehringer-ingelheim.us/csr  to learn more about how we make more health through our Corporate Social Responsibility initiatives.
For more information please visit https://www.boehringer-ingelheim.us, or follow us on Twitter @BoehringerUS.

Editor Details

Related Links

Last Updated: 13-Dec-2018